Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPD52L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NECAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAB31 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBPJ - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEBL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EHD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NFKBIE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POGLUT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLHDC10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRPS12 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAPN11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POLR2G - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AMPD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ISG20 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LSM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SERPINE1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OSGIN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLHL18 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SH3BP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on